Gene-based association identifies SPATA13-AS1 as a pharmacogenomic predictor of inhaled short-acting beta-agonist response in multiple population groups

Gene-based association identifies SPATA13-AS1 as a pharmacogenomic predictor of inhaled short-acting beta-agonist response in multiple population groups

Inhaled short-acting beta-agonist (SABA) medication is commonly used in asthma patients to rapidly reverse airway obstruction and improve acute symptoms. We performed a genome wide association study of SABA medication response using gene-based association tests. A linear mixed model approach was fir...

Full description

Bibliographic Details
Main Authors: Padhukasahasram, Badri K., Yang, James J., Levin, Albert M., Yang, Mao, Burchard, Esteban G., Kumar, Rajesh, Kwok, Pui-Yan, Seibold, Max A., Lanfear, David E., Williams, L. Keoki
Format: Online
Language:English
Published: 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4098013/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4098013/

Similar Items